2016
DOI: 10.1371/journal.pone.0146653
|View full text |Cite
|
Sign up to set email alerts
|

Role of Prolactin Receptors in Lymphangioleiomyomatosis

Abstract: Pulmonary lymphangioleiomyomatosis (LAM) is a rare lung disease caused by mutations in the tumor suppressor genes encoding Tuberous Sclerosis Complex (TSC) 1 and TSC2. The protein product of the TSC2 gene is a well-known suppressor of the mTOR pathway. Emerging evidence suggests that the pituitary hormone prolactin (Prl) has both endocrine and paracrine modes of action. Here, we have investigated components of the Prl system in models for LAM. In a TSC2 (+/-) mouse sarcoma cell line, down-regulation of TSC2 us… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
7
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 36 publications
(34 reference statements)
2
7
0
Order By: Relevance
“…Finally, it is possible that GBM represents a state of either increased Prl production or increased Prl sensitivity. In support of the latter, loss of TSC2 (a well-known suppressor of mTOR) function leads to increased Prl sensitivity of lymphangioleiomyomatosis (LAM) cells, a sarcoma–like cell type [ 36 , 37 ]. The mTOR system is an important signal integrator and regulator of protein synthesis and seems to be over-active in GBM [ 17 , 38 , 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…Finally, it is possible that GBM represents a state of either increased Prl production or increased Prl sensitivity. In support of the latter, loss of TSC2 (a well-known suppressor of mTOR) function leads to increased Prl sensitivity of lymphangioleiomyomatosis (LAM) cells, a sarcoma–like cell type [ 36 , 37 ]. The mTOR system is an important signal integrator and regulator of protein synthesis and seems to be over-active in GBM [ 17 , 38 , 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…Activation of the PRLR by PRL leads to activation of the JAK/STAT pathway [39,42]. Several publications suggest that activation of the PRL/PRLR signaling pathways is linked to cancer via activation of PI3K, AKT, and MAPK pathways, which are important in tumorigenesis [43][44][45]. These pathways are also known to be activated by HCMV infection.…”
Section: Introductionmentioning
confidence: 99%
“…The relationship between LAM and PRL is the third point of consideration. Studies have found that LAM cells also contribute to the increased expression of PRL receptors [ 10 ]. Hence, patients with LAM are more susceptible to mTOR activation by PRLs.…”
Section: Discussionmentioning
confidence: 99%